Vincerx Pharma, Inc. Warrant
VINCW
VINCW was delisted on the 5th of May, 2021.
18 hedge funds and large institutions have $13.6M invested in Vincerx Pharma, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$1.66M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.1M |
| 3 |
PA
Perceptive Advisors
New York
|
+$998K |
| 4 |
SCM
Sio Capital Management
New York
|
+$698K |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$665K |
Top Sellers
VINCW Hedge Fund Activity: Q4 2020 in Review
18 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Warrant (VINCW) for Q4 2020, worth a combined $13.6M.
Buyers outnumbered sellers: 18 funds opened new VINCW positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $1.66M.
- 18 institutional investors held Vincerx Pharma, Inc. Warrant (VINCW) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $13.6M of Vincerx Pharma, Inc. Warrant stock for Q4 2020.
- 18 funds opened new Vincerx Pharma, Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +18 holders.
- The largest Vincerx Pharma, Inc. Warrant buyer in Q4 2020 was RTW Investments, an estimated $1.66M added.
Based on aggregated 13F filings for Q4 2020.